FIELD: medicine. SUBSTANCE: the present innovation includes the method to manipulate binding process of endothelial cells with lymphocytes mediated with vascular adhesion protein-1 (VAP-1) including either inhibition or taking antilogarithms of aminooxidase enzymatic activity in mentioned endothelial cells. The present method mediates earlier interactions in the processes of binding lymphocytes and endothelial cells. EFFECT: higher efficiency. 2 cl, 6 dwg, 2 tbl
